Cochlear | COH - Sales Revenues

Stock Price
93.00
Daily Change
-2.25 -2.36%
Monthly
-44.28%
Yearly
-65.66%
Q2 Forecast
95.52

Cochlear reported AUD1.18B in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Ansell USD 1.03B 192.2M Dec/2025
Avita Medical AUD 17.61M 805K Dec/2025
Cochlear AUD 1.18B 590.35M Dec/2025
CSL USD 8.33B 4.79B Dec/2025
Fisher Paykel Healthcare NZD 1.1B 21.3M Dec/2025
Healius AUD 688.1M 245.8M Dec/2025
Integral Diagnostics AUD 238.44M 7.19M Jun/2024
Mayne Pharma AUD 212.07M 17.03M Dec/2025
Mesoblast USD 30.3M 17.1M Dec/2025
Monash IVF AUD 137.86M 72.09M Dec/2025
Nanosonics AUD 102.23M 2.8M Dec/2025
Polynovo AUD 70.33M 35.75M Dec/2025
Ramsay Health Care AUD 9.34B 82.2M Dec/2025
Regis Healthcare AUD 667.75M 70.63M Dec/2025
ResMed USD 1.42B 87.23M Dec/2025
Sigma Healthcare AUD 1.68B 188.65M Dec/2024
Somnomed AUD 45.11M 1.46M Dec/2023
Sonic Healthcare AUD 5.45B 470M Dec/2025
Telix Pharmaceuticals AUD 413.44M 103.71M Dec/2025